The global liver cancer diagnostics market size is expected
to reach USD 15.4 billion by 2025, according to a new report by Grand View
Research, Inc. The market is projected to expand at a CAGR of 8.1% over the
estimated time period. Rise in disease incidence coupled with growing demand
for novel diagnosis products are thrusting the growth of the market.
Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer
in adults. It is among the common causes of death in people with liver
cirrhosis and the third-leading cause of cancer deaths across the globe. Poor
survival rate and lack of therapies has made this disease a crucial health
issue worldwide.
Government and some global health
organizations are undertaking initiatives to raise awareness regarding liver
cancer through various campaigns. These programs aim to create awareness about
signs, symptoms, and complications associated with carcinomas. High costs
associated with cancer treatments compared to other diseases have led to
increasingly rigid treatment guidelines for expensive drugs and diagnostic
tests across various markets. For instance, the Affordable Care Act, designed
to improve quality of healthcare and reduce the cost associated with it. This
act covers reimbursement for cancer diagnosis and treatment up to a certain
extent. Governments in other countries are also taking efforts to overcome
challenges, such as cost and access to cancer care.
Such efforts and insurance policies that cover
cost of diagnosis and treatment of carcinomas are supporting market growth.
Newer techniques developed for hepatocellular carcinoma render both liver
transplant, as well as surgical resection, more effective and safer. Several
etiological factors of HCC such as hepatitis infection and cirrhosis are
modifiable and thus present a strong prospect to reduce disease mortality by
preventive strategies. Key players and medical institutions are focusing on the
development of advanced tests for HCC diagnosis. These factors along with high
unmet needs are expected to propel the growth of liver cancer diagnostics
market through the forecast period.
For full research report on Liver
Cancer Diagnostic Market visit here: https://www.grandviewresearch.com/industry-analysis/liver-cancer-diagnostic-market
Further key
findings from the study suggest:
- Increasing awareness about liver cancer across
the globe is expected to be the major factor driving the market growth
- Laboratory tests emerged as the largest
segment owing to increased demand for effective diagnostic tests for HCC
- Oncofetal and Glucoprotein antigens accounted
for the largest share in biomarkers segment
- North America led the global liver cancer
diagnostic market in 2017 and will maintain the dominance in future on
account of rising awareness about early diagnosis and demand for novel
diagnostic tests in the region
- Illumina, Inc.; Qiagen; F. Hoffmann-La Roche
Ltd.; Siemens Healthcare GmbH; and Thermo Fisher Scientific are some of
the leading industry participants
Get request sample of this report here: https://www.grandviewresearch.com/industry-analysis/liver-cancer-diagnostic-market/request/rs1
Grand
View Research has segmented the global liver cancer diagnostics market on the
basis of screening type and region:
Liver Cancer
Diagnostics Screening Type Outlook (Revenue, USD Million, 2014 - 2025)
- Laboratory Tests
- Biomarkers
- Oncofetal and
Glycoprotein Antigens
- Enzymes and
Isoenzymes
- Growth Factors and
Receptors
- Molecular Markers
- Pathological
Biomarkers
- Blood Tests
- Imaging
- Endoscopy
- Biopsy
- Others
Liver Cancer
Diagnostics Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- Middle East &
Africa
- Saudi Arabia
- South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment